Huile Sommeil
Food supplement declared in France, declaration No 2024-6-27, decision dated 2 June 2024
Huile Sommeil (Flower Lab) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). 1 point in its composition requires a check (prohibited substance, dose or novel food).
- Brand
- Flower Lab
- Food business operator placing the product on the market
- FLOWER LAB
- Status
- Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
- Form
- Autre : Huile
- Daily dose
- 50mg
- Directions for use
- 5 doses maximum recommandé = 50mg
- Intended populations
- Personnes de plus de 60 ans, Homme, Femme
- Not recommended for (according to the manufacturer)
- Adolescents (moins de 18 ans), Femmes allaitantes, Enfants (moins de 12 ans), Enfants en bas âge (1 à 3 ans), Femmes enceintes, Nourrissons (moins de 1 an), Problèmes cardiaques, Sous anticoagulants, Sous antidépresseurs, Sous antidiabétiques, Sous traitement antihypertenseur, Sous traitement médicamenteux, Sous traitement pour la thyroïde, Enfants (de moins de 6 ans), Enfants (de moins de 10 ans)
- Objectives stated by the manufacturer (these are not authorised claims)
- Sommeil
- Flavourings
- Camomille et Lavande
Declaration 331859, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- À vérifier
Cannabis sativa L.: dangerous plant prohibited in food in Belgium (list 1). L'utilisation des graines de chanvre et des produits dérivés peut être autorisée si la denrée alimentaire est conforme aux dispositions de la section 2.6 (équivalents de delta-9-tétrahydrocannabinol (Δ9-THC)) de l'annexe du règlement (UE) 2023/915 de la Commission du 25 avril 2023 concernant les teneurs maximales pour certains contaminants dans les denrées alimentaires et abrogeant le règlement (CE) no 1881/2006.
Source: Belgium, Royal Decree of 31 August 2021, plant lists (annex replaced on 30 January 2024), arrêté royal du 31 août 2021, annexe remplacée le 30 janvier 2024, liste 1, page PDF 67.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Cannabis sativa L. | Graine (huile) | Pression à froid | 48 mg |
| Chamaemelum nobile (L.) All. | Essence (fleur) | Autre extrait fluide | 0.63 mg |
| Lavandula angustifolia Mill. | Essence (fleur) | Autre extrait fluide | 0.63 mg |
Other active ingredients
| Name | Per day |
|---|---|
| Mélatonine | not declared |
Other ingredients
Huile de coco
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Label warnings
Les informations fournies ne sont pas destinées à diagnostiquer, traiter, guérir ou prévenir une quelconque maladie. Elles ne doivent pas être interprétées comme une instruction ou un avis médical destinés à remplacer les conseils de votre médecin ou d’autres professionnels de santé.Nous conseillons l’avis préalable d’un médecin avant la consommation de ce complément alimentaire pour les personnes souffrant de maladies inflammatoires, auto-immunes, d’épilepsie, d’asthme, de troubles de l’humeur, du comportement ou de la personnalité, ainsi que les personnes suivant un traitement médicamenteux.Nous conseillons l’avis préalable d’un médecin avant la consommation de ce complément alimentaire pour les personnes souffrant de maladies inflammatoires, auto-immunes, d’épilepsie, d’asthme, de troubles de l’humeur, du comportement ou de la personnalité, ainsi que les personnes suivant un traitement médicamenteux.Ne pas conduire après la prise de ce produit.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Chamaemelum nobile (L.) All.
Read the warning, when it applies and the studies cited
Roman Chamomile - Chamaemelum Nobile
Route of administration: Oral (Wichtl 2004; Bradley 1992)
Cautions and warnings
Ask a healthcare practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (Brinker 2010; Mills and Bone 2000; Blumenthal et al. 1998).
3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
- Mélatonine
Read the warning, when it applies and the studies cited
MELATONIN - Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking medications for seizure, blood pressure, to suppress the immune system, to affect mental state or increase sedation, steroids or blood thinners (Wirtz et al. 2008; IOM 2004; Herxheimer and Petrie 2002; Lusardi et al. 2000; Maestroni 1993).
5 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have cardiovascular, immune, liver or kidney disease, seizure disorder, asthma or diabetes (Peschke and Mühlbauer 2010; Carrillo-Vico et al. 2005; IOM 2004; der Marderosian and Beuttlers 2003; Sutherland et al. 2003; Calvo et al. 2002; Herxheimer and Petrie 2002; Sutherland et al. 2002; Cagnacci et al. 2001a; Arangino et al. 1999; Sheldon 1998; Maestroni 1993).
12 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
When using this product avoid taking with alcohol or products that cause drowsiness (Herxheimer and Petrie 2002; Holliman and Chyka 1997).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
When using this product avoid driving or using machinery for 5 hours (Avery et al. 1998; Suhner et al. 1998b).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician if sleeplessness persists for more than 4 weeks (chronic insomnia) (Buscemi et al. 2004; IOM 2004; Dipiro et al. 2002).
3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Contraindications
Do not use if you are pregnant or breastfeeding (IOM 2004).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Stop use if allergy occurs or if you experience headache, confusion, or nausea (Herxheimer and Petrie 2002).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Health Canada monograph dated 19 December 2025
MELATONIN - Sublingual
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking medications for seizure, blood pressure, to suppress the immune system, to affect mental state or increase sedation, steroids or blood thinners (Wirtz et al. 2008; IOM 2004; Herxheimer and Petrie 2002; Lusardi et al. 2000; Maestroni 1993).
5 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a cardiovascular, immune, liver or kidney disease, seizure disorder, asthma or diabetes (Peschke and Mühlbauer 2010; Carrillo-Vico et al. 2005; IOM 2004; der Marderosian and Beuttlers 2003; Sutherland et al. 2003; Calvo et al. 2002; Herxheimer and Petrie 2002; Sutherland et al. 2002; Cagnacci et al. 2001a; Arangino et al. 1999; Sheldon 1998; Maestroni 1993).
12 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
When using this product avoid taking with alcohol or products that cause drowsiness (Herxheimer and Petrie 2002; Holliman and Chyka 1997).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
When using this product avoid driving or using machinery for 5 hours (Avery et al. 1998; Suhner et al. 1998b).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician if sleeplessness persists for more than 4 weeks (chronic insomnia) (Buscemi et al. 2004; IOM 2004; Dipiro et al. 2002).
3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Contraindications
Do not use if you are pregnant or breastfeeding (IOM 2004).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Stop use if allergy occurs or if you experience headache, confusion, or nausea (Herxheimer and Petrie 2002).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- Huile sommeil Jaane, declared in 2024 : different composition: 3 ingredient(s) added, 3 missing
- Huile sommeil Golden CBD, declared in 2024 : different composition: 1 ingredient(s) added, 3 missing
Brand : Flower Lab
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.